Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
THMO | F | ThermoGenesis Holdings, Inc. | 0.00 | |
APRE | F | Aprea Therapeutics, Inc. | -1.46 | |
LXRX | F | Lexicon Pharmaceuticals, Inc. | 11.88 | |
EQ | F | Equillium, Inc. | -1.25 | |
SLRX | F | Salarius Pharmaceuticals, Inc. | -6.16 | |
SAGE | F | Sage Therapeutics, Inc. | 6.60 | |
BLRX | F | BioLineRx Ltd. | -13.98 | |
ONCT | F | Oncternal Therapeutics, Inc. | -1.72 | |
ORGS | F | Orgenesis Inc. | -41.71 | |
REGN | F | Regeneron Pharmaceuticals, Inc. | -0.87 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HELX | D | Franklin Genomic Advancements ETF | 5.67 | |
BBP | C | BioShares Biotechnology Products Fund | 5.15 | |
SHLD | C | Global X Defense Tech ETF | 4.86 | |
HACK | B | ETFMG Prime Cyber Security ETF | 4.51 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 4.37 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles